Evidence map›Paper›PMID 34590248›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2021

Studying Bacterial Persistence: Established Methods and Current Advances.

Elen Louwagie, Laure Verstraete, Jan Michiels, Natalie Verstraeten

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elen LouwagieVIB-KU Leuven Center for Microbiology, VIB, Leuven, Belgium.ORCID https://orcid.org/0000-0001-8416-363X
Laure VerstraeteVIB-KU Leuven Center for Microbiology, VIB, Leuven, Belgium.ORCID https://orcid.org/0000-0002-1819-9906
Jan MichielsVIB-KU Leuven Center for Microbiology, VIB, Leuven, Belgium. jan.michiels@kuleuven.be.ORCID https://orcid.org/0000-0001-5829-0897
Natalie VerstraetenVIB-KU Leuven Center for Microbiology, VIB, Leuven, Belgium.ORCID https://orcid.org/0000-0002-9548-4647

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To date, we are living in a postantibiotic era in which several human pathogens have developed multidrug resistance and very few new antibiotics are being discovered. In addition to the problem of antibiotic resistance, every bacterial population harbors a small fraction of transiently antibiotic-tolerant persister cells that can survive lethal antibiotic attack. Upon cessation of the treatment, these persister cells wake up and give rise to a new, susceptible population. Studies conducted over the past two decades have demonstrated that persister cells are key players in the recalcitrance of chronic infections and that they contribute to antibiotic resistance development. As a consequence, the scientific interest in persistence has increased tremendously and while some questions remain unanswered, many important insights have been brought to light thanks to the development of dedicated techniques. In this chapter, we provide an overview of well-established methods in the field and recent advances that have facilitated the investigation of persister cells and we highlight the challenges to be tackled in future persistence research.

Indexed as

BacteriaPersistent InfectionAnti-Bacterial AgentsHumansAnti-Bacterial AgentsAntibioticsAntibiotic toleranceBacterial persistencePersistence

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.